Security key
67059V209
Nuo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AURX)
CUSIP: 67059V209
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 4,700
- Total 13F value
- $4,277
- Share change
- 0
- SEC-reported price per share
- $0.91
- Number of holders
- 1
- Shares outstanding
- 48,512,931
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
AURX full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Nuo Therapeutics, Inc. SEC filings
Nuo Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 67059V209
Recent filing periods:
Ownership snapshot
Top reported holders of AURX - Nuo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Pittman Scott M.
Disclosed value leader
Charles E. Sheedy
Comparable rows
4/7
Latest evidence
29 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 12%
3 rows are not safely comparable across share classes.
13D/G row: Pittman Scott M.
Showing 1-6 of 7 holder rows.
Quick read
Pittman Scott M. leads the comparable SEC ownership view at 12%.
4 of 7 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Pittman Scott M.'s linked filing trail.
Comparable ownership
Top 4
Pittman Scott M.
12%
Jacobs Paul Anthony
6.6%
Charles E. Sheedy
24%
Ancora Advisors LLC
0.01%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 7 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Pittman Scott M. |
13D/G
3/4/5
Director, 10%+ Owner
|
12%
|
$8,159,875
5,627,500 shares
|
+$25,302 | 29 May 2026 |
| Jacobs Paul Anthony |
13D/G
|
6.6%
|
$6,526,175
3,183,500 shares
|
$0 | 23 Jan 2026 |
| Charles E. Sheedy |
3/4/5
10%+ Owner
|
24%
|
$17,360,960
11,574,198 shares
|
— | 30 Jul 2025 |
| Ancora Advisors LLC |
13F
Company
|
0.01%
|
$6,815
4,700 shares
|
— | 31 Mar 2026 |
| Peter Clausen |
3/4/5
CSO/COO
|
—
mixed-class rows
|
$312,884
838,528 shares
mixed-class rows
|
— | 29 Jun 2026 |
| C. Eric Winzer |
3/4/5
Director
|
—
mixed-class rows
|
$250,922
203,050 shares
mixed-class rows
|
— | 29 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
4,700
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
1
Q2 2026 holders
1
Holder diff
0
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend